Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -152,852 | -99,357 | -52,931 | -199,590 | -150,943 |
| Depreciation Amortization | 7,370 | 4,488 | 2,166 | 6,785 | 4,786 |
| Accounts receivable | -3,200 | -1,719 | -1,419 | -7,862 | -7,928 |
| Accounts payable and accrued liabilities | 1,437 | 903 | 711 | -3,301 | -1,215 |
| Other Working Capital | -2,211 | -1,999 | 602 | -13,308 | -16,918 |
| Other Operating Activity | 19,856 | 12,396 | 5,860 | 26,454 | 20,885 |
| Operating Cash Flow | $-129,600 | $-85,288 | $-45,011 | $-190,822 | $-151,333 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -26 | -26 | -10 | -206 | -156 |
| Purchase Of Investment | -247,911 | -205,773 | -93,882 | -178,489 | -90,329 |
| Sale Of Investment | 162,855 | 99,286 | 47,413 | 257,145 | 202,454 |
| Investing Cash Flow | $-85,082 | $-106,513 | $-46,479 | $78,450 | $111,969 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | 73,682 |
| Common Stock Issued | 168,115 | 166,875 | 164,829 | 50,696 | 15,687 |
| Other Financing Activity | 0 | 0 | 0 | 73,609 | 0 |
| Financing Cash Flow | $168,115 | $166,875 | $164,829 | $124,305 | $89,369 |
| Exchange Rate Effect | -15 | -32 | -80 | 19 | -26 |
| Beginning Cash Position | 130,689 | 130,689 | 130,689 | 118,737 | 118,737 |
| End Cash Position | 84,107 | 105,731 | 203,948 | 130,689 | 168,716 |
| Net Cash Flow | $-46,582 | $-24,958 | $73,259 | $11,952 | $49,979 |
| Free Cash Flow | |||||
| Operating Cash Flow | -129,600 | -85,288 | -45,011 | -190,822 | -151,333 |
| Capital Expenditure | -26 | -26 | -10 | -206 | -156 |
| Free Cash Flow | -129,626 | -85,314 | -45,021 | -191,028 | -151,489 |